Other

Private equity securities at cost

Pfizer Private equity securities at cost decreased by 1.1% to $688.00M in Q1 2026 compared to the prior quarter.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2025
Last reportedQ1 2026
Metric ID: other_private_equity_investments

Historical Data

2 periods
 Q4 '25Q1 '26
Value$696.00M$688.00M
QoQ Change—-1.1%
Range$688.00M – $696.00M

Frequently Asked Questions

What is Pfizer's private equity securities at cost?
Pfizer (PFE) reported private equity securities at cost of $688.00M in Q1 2026.